These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15758270)

  • 21. The "bone morphogenic proteins" pathways in bone and joint diseases: translational perspectives from physiopathology to therapeutic targets.
    Biver E; Hardouin P; Caverzasio J
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):69-81. PubMed ID: 22749766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic breast cancer induces an osteoblast inflammatory response.
    Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
    Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone.
    Kominsky SL; Davidson NE
    J Clin Oncol; 2006 May; 24(15):2227-9. PubMed ID: 16636338
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanisms of bone remodeling induced by tumors: tumor humors.
    Tashjian AH
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1869-72. PubMed ID: 6800026
    [No Abstract]   [Full Text] [Related]  

  • 25. Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity.
    Clézardin P; Ebetino FH; Fournier PG
    Cancer Res; 2005 Jun; 65(12):4971-4. PubMed ID: 15958534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of bone metastasis: the role of osteoprotegerin and of the host-tissue microenvironment-related survival factors.
    Fili S; Karalaki M; Schaller B
    Cancer Lett; 2009 Sep; 283(1):10-9. PubMed ID: 19201081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of cancer metastasis to bone.
    Oni OO
    J Bone Joint Surg Am; 1987 Feb; 69(2):309-10. PubMed ID: 3805100
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experience of vitamin K2 in Thailand].
    Bunyaratavej N
    Clin Calcium; 2007 Nov; 17(11):1752-60. PubMed ID: 17982197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of osteotropism on both sides of the breast cancer-bone interaction.
    Moreau J; Anderson KM; Mauney JR; Kaplan D; Rosenblatt M
    Ann N Y Acad Sci; 2007 Nov; 1117():328-44. PubMed ID: 17584985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone metastasis: can osteoclasts be excluded?
    Martin TJ; Mundy GR
    Nature; 2007 Feb; 445(7130):E19; discussion E19-20. PubMed ID: 17314931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.
    Loberg RD; Gayed BA; Olson KB; Pienta KJ
    J Cell Biochem; 2005 Oct; 96(3):439-46. PubMed ID: 15988761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of VX-2 carcinoma implanted in bone in rabbits.
    Enneking WF; Flynn L
    Cancer Res; 1968 Jun; 28(6):1007-13. PubMed ID: 5658436
    [No Abstract]   [Full Text] [Related]  

  • 33. [Loss of heterozygosity on chromosome 10 is associated with bone metastasis of human prostate cancer].
    Hou Z; Luo Y; Jiang YG; Li MC; Lin YH; Zhang YP
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):879-83. PubMed ID: 19157094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteotropic cancers: from primary tumor to bone.
    Buijs JT; van der Pluijm G
    Cancer Lett; 2009 Jan; 273(2):177-93. PubMed ID: 18632203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromal cells promote bone invasion by suppressing bone formation in ameloblastoma.
    Sathi GS; Nagatsuka H; Tamamura R; Fujii M; Gunduz M; Inoue M; Rivera RS; Nagai N
    Histopathology; 2008 Oct; 53(4):458-67. PubMed ID: 18983611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follistatin as an inhibitor of experimental metastasis.
    Talmadge JE
    Clin Cancer Res; 2008 Feb; 14(3):624-6. PubMed ID: 18245519
    [No Abstract]   [Full Text] [Related]  

  • 37. Antivascular therapy of cancer metastasis.
    Fidler IJ
    J Surg Oncol; 2006 Sep; 94(3):178-80. PubMed ID: 16900530
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular mechanisms and treatment of bone metastasis.
    Clines GA; Guise TA
    Expert Rev Mol Med; 2008 Mar; 10():e7. PubMed ID: 18321396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the receptor activator of nuclear factor-kappaB (RANK) ligand in prostate cancer bone metastases.
    Saad F; Markus R; Goessl C
    BJU Int; 2008 May; 101(9):1071-5. PubMed ID: 18070191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylases in control of skeletogenesis.
    Westendorf JJ
    J Cell Biochem; 2007 Oct; 102(2):332-40. PubMed ID: 17661352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.